Picard Medical (PMI) Amends Form 3 to Adjust Option Exercise Price After Stock Split
Rhea-AI Filing Summary
Picard Medical, Inc. (PMI) reporting person Matt Schuster filed an amended Form 3 disclosing employee stock options granted on June 28, 2024. The filing shows three option awards underlying common stock: 102,239, 408,956, and 68,608 shares, each with an exercise price adjusted to $0.71 after an overall forward split of 1 for 2.1524. Vesting for each award began in 2023 with a one-quarter cliff at the first anniversary and remaining amounts vesting monthly over the following 36 months, subject to continued service. The amendment corrects the conversion/exercise price to reflect the stock split.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine disclosure of option grants with split-adjusted exercise price; no new cash flows or revenue impact disclosed.
The Form 3/A documents equity compensation for an officer, specifying three option awards totaling 579,803 underlying shares and an adjusted exercise price of $0.71 following corporate stock-split adjustments. The vesting schedules are standard (quarterly cliff then monthly ratable over 36 months) and contingent on continued service. This filing corrects conversion pricing; it does not report exercised options, transfers, or changes in control.
TL;DR: Corporate governance disclosure appears compliant; amendment clarifies split-adjusted pricing for officer-held options.
The amendment transparently updates the exercise price to reflect a combined forward and reverse split (net forward 1 for 2.1524). It identifies the reporting person as Chief Operating Officer and confirms normal service-based vesting terms. The document is a routine Section 16 filing correction and does not indicate departures, exercises, or pledging of securities.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Employee Stock Option (right to buy) | -- | -- | -- |
| holding | Employee Stock Option (right to buy) | -- | -- | -- |
| holding | Employee Stock Option (right to buy) | -- | -- | -- |
Footnotes (1)
- On June 28, 2024, the reporting person was granted 102,239 options, with a vesting commencement date of May 29, 2023. One quarter of the options cliff vested upon the first anniversary of the vesting commencement date, and the remaining options have vested or will vest ratably in equal monthly installments over the 36 months following the first anniversary of the vesting commencement date, generally subject to the continued service of the reporting person through each applicable vesting date. As adjusted to reflect the Company's 1 for 2.2 forward stock split of the Company's common stock and the Company's 1.0221 for 1 reverse stock split of the Company's common stock, resulting in an overall forward stock split of 1 for 2.1524. On June 28, 2024, the reporting person was granted 408,956 options, with a vesting commencement date of November 27, 2023. One quarter of the options cliff vested upon the first anniversary of the vesting commencement date, and the remaining options have vested or will vest ratably in equal monthly installments over the 36 months following the first anniversary of the vesting commencement date, generally subject to the continued service of the reporting person through each applicable vesting date. On June 28, 2024, the reporting person was granted 68,608 options, with a vesting commencement date of May 29, 2023. One quarter of the options cliff vested upon the first anniversary of the vesting commencement date, and the remaining options have vested or will vest ratably in equal monthly installments over the 36 months following the first anniversary of the vesting commencement date, generally subject to the continued service of the reporting person through each applicable vesting date.
